Riecher-Rossler A, Butler S, Kulkarni J. Sex and gender differences in schizophrenic psychoses-a critical review. Arch Women’s Ment Health. 2018;21:627–48.

Article  Google Scholar 

NIH Inclusion Outreach Toolkit: How to Engage, Recruit, and Retain Women in Clinical Research. https://orwh.od.nih.gov/toolkit/nih-policies-inclusion/guidelines, Accessed Date Accessed 2015 Accessed. (2015).

Li X, Zhou W, Yi Z. A glimpse of gender differences in schizophrenia. Gen Psychiatr. 2022;35:e100823.

Article  PubMed  PubMed Central  Google Scholar 

Hafner H, Maurer K, Loffler W, Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry. 1993;162:80–86.

Article  CAS  PubMed  Google Scholar 

Riecher-Rossler A, Hafner H, Stumbaum M, Maurer K, Schmidt R. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull. 1994;20:203–14.

Article  CAS  PubMed  Google Scholar 

Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2009;44:83–98.

Article  PubMed  Google Scholar 

Zhang B, Han M, Tan S, De Yang F, Tan Y, Jiang S, et al. Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients. Sci Rep. 2017;7:11821.

Article  PubMed  PubMed Central  Google Scholar 

Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet. 2002;71:337–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scheggia D, Mastrogiacomo R, Mereu M, Sannino S, Straub RE, Armando M, et al. Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. Nat Commun. 2018;9:2265.

Article  PubMed  PubMed Central  Google Scholar 

Mastrogiacomo R, Trigilio G, Devroye C, Dautan D, Ferretti V, Losi G, et al. Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia. Mol Psychiatry. 2022;27:4201–17.

Article  CAS  PubMed  Google Scholar 

Ghiani CA, Starcevic M, Rodriguez-Fernandez IA, Nazarian R, Cheli VT, Chan LN, et al. The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth. Mol Psychiatry. 2010;15:204–115.

Article  CAS  Google Scholar 

Ma X, Fei E, Fu C, Ren H, Wang G. Dysbindin-1, a schizophrenia-related protein, facilitates neurite outgrowth by promoting the transcriptional activity of p53. Mol Psychiatry. 2011;16:1105–16.

Article  CAS  PubMed  Google Scholar 

Ji Y, Yang F, Papaleo F, Wang HX, Gao WJ, Weinberger DR, et al. Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proc Natl Acad Sci USA. 2009;106:19593–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Talbot K, Ong W-Y, Blake D, Tang J, Louneva N, Carlson G, et al. Dysbindin-1 and its protein family. Handbook of neurochemistry and molecular neurobiology. US: Springer; 2009. p. 107–241.

Leggio GM, Torrisi SA, Mastrogiacomo R, Mauro D, Chisari M, Devroye C, et al. The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans. Mol Psychiatry. 2021;26:1272–85.

Article  CAS  PubMed  Google Scholar 

Dickman DK, Davis GW. The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis. Science. 2009;326:1127–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mullin AP, Sadanandappa MK, Ma W, Dickman DK, VijayRaghavan K, Ramaswami M, et al. Gene dosage in the dysbindin schizophrenia susceptibility network differentially affect synaptic function and plasticity. J Neurosci. 2015;35:325–38.

Article  PubMed  PubMed Central  Google Scholar 

Huang CCY, Muszynski KJ, Bolshakov VY, Balu DT. Deletion of Dtnbp1 in mice impairs threat memory consolidation and is associated with enhanced inhibitory drive in the amygdala. Transl Psychiatry. 2019;9:132.

Article  PubMed  PubMed Central  Google Scholar 

Williams OOF, Coppolino M, George SR, Perreault ML. Sex Differences in Dopamine Receptors and Relevance to Neuropsychiatric Disorders. Brain Sci. 2021;11:1199.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weickert CS, Rothmond DA, Hyde TM, Kleinman JE, Straub RE. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophr Res. 2008;98:105–10.

Article  PubMed  Google Scholar 

Winterer G, Weinberger DR. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 2004;27:683–90.

Article  CAS  PubMed  Google Scholar 

Papaleo F, Burdick MC, Callicott JH, Weinberger DR. Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans. Mol Psychiatry. 2014;19:311–6.

Article  CAS  PubMed  Google Scholar 

Savage JE, Jansen PR, Stringer S, Watanabe K, Bryois J, de Leeuw CA, et al. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 2018;50:912–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Waddington JL, Zhen X, O’Tuathaigh CMP. Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond. Front Pharm. 2019;10:1638.

Article  CAS  Google Scholar 

Meyers B, D’Agostino A, Walker J, Kritzer MF. Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects on monoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adult male rats. Neuroscience. 2010;165:850–62.

Article  CAS  PubMed  Google Scholar 

Schendzielorz N, Rysa A, Reenila I, Raasmaja A, Mannisto PT. Complex estrogenic regulation of catechol-O-methyltransferase (COMT) in rats. J Physiol Pharm. 2011;62:483–90.

CAS  Google Scholar 

Chen J, Song J, Yuan P, Tian Q, Ji Y, Ren-Patterson R, et al. Orientation and cellular distribution of membrane-bound catechol-O-methyltransferase in cortical neurons: implications for drug development. J Biol Chem. 2011;286:34752–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzalez-Castro TB, Hernandez-Diaz Y, Juarez-Rojop IE, Lopez-Narvaez ML, Tovilla-Zarate CA, Fresan A. The Role of a Catechol-O-Methyltransferase (COMT) Val158Met Genetic Polymorphism in Schizophrenia: A Systematic Review and Updated Meta-analysis on 32,816 Subjects. Neuromol Med. 2016;18:216–31.

Article  CAS  Google Scholar 

Xie T, Ho SL, Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharm. 1999;56:31–38.

Article  CAS  Google Scholar 

Dumas JA, Makarewicz JA, Bunn J, Nickerson J, McGee E. Dopamine-dependent cognitive processes after menopause: the relationship between COMT genotype, estradiol, and working memory. Neurobiol Aging. 2018;72:53–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dean B, Parkin GM, Gibbons AS. Associations between catechol-O-methyltransferase (COMT) genotypes at rs4818 and rs4680 and gene expression in human dorsolateral prefrontal cortex. Exp Brain Res. 2020;238:477–86.

Article  CAS  PubMed  Google Scholar 

Eugene AR, Masiak J. A pharmacodynamic modelling and simulation study identifying gender differences of daily olanzapine dose and dopamine D2-receptor occupancy. Nord J Psychiatry. 2017;71:417–24.

Article  PubMed  PubMed Central  Google Scholar 

Gonzalez-Rodriguez A, Seeman MV. Pharmacotherapy for schizophrenia in postmenopausal women. Expert Opin Pharmacother. 2018;19:809–21.

Article  CAS  PubMed  Google Scholar 

Torretta S, Rampino A, Basso M, Pergola G, Di Carlo P, Shin JH, et al. NURR1 and ERR1 Modulate the Expression of Genes of a DRD2 Coexpression Network Enriched for Schizophrenia Risk. J Neurosci. 2020;40:932–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pergola G, Di Carlo P, D’Ambrosio E, Gelao B, Fazio L, Papalino M, et al. DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia. Transl psychiatry. 2017;7:e1006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hwang WJ, Lee TY, Kim NS, Kwon JS. The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders. Int J Mol Sci. 2020;22:373.

Article  PubMed  PubMed Central  Google Scholar 

Seamans JK, Lapish CC, Durstewitz D. Comparing the prefrontal cortex of rats and primates: insights from electrophysiology. Neurotox Res. 2008;14:249–62.

Article  PubMed  Google Scholar 

Papaleo F, Yang F, Garcia S, Chen J, Lu B, Crawley JN, et al. Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol Psychiatry. 2012;17:85–98.